Delivery Order SPE2DB20D1100-SPE2DB25FB7C8

Award Date 4/14/25
Potential Completion Date 5/5/25
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $8,630.28, is for the delivery of OFEV 100 MG CAPSULE 60S, a specialty pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $8,590.58 and an ultimate completion date of May 5, 2025. The contract covers the procurement of OFEV 150 MG capsules, a specialty pharmaceutical product. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $8,590.58 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which has an ultimate completion date of January 24, 2025, is for the supply of OFEV 150 MG CAPSULE 60S medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $8,590.58 firm fixed-price delivery order is for the supply of OFEV 150 mg capsules. The contract has an ultimate completion date of February 28, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $25,771.74, is for the delivery of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,590.58, is for the delivery of OFEV 150 MG Capsules over the performance period ending on April 9, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,590.58, is a delivery order for the supply of OFEV 150 MG capsules. The contract has a firm fixed-price pricing type and an ultimate completion date of May 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply OFEV 100 mg capsules for a total ceiling value of $7,915.84. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of November 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,590.58 firm-fixed-price delivery order covers the supply of OFEV 150 MG capsules to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,590.58, is a delivery order for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of April 14, 2025 and is a firm-fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB7C8
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,590.58, is for the delivery of OFEV 150 MG capsules.

The award is a delivery order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any major subcontractors. The contract is a firm fixed-price arrangement with a performance period ending on May 5, 2025.

Generated 7/14/25, 11:04 AM